Making the invisible visible: the availability and desirability of adherence data in routine CF care– findings from a national questionnaire survey [version 2; peer review: 2 approved]

Background: Inhaled medications for cystic fibrosis (CF) are effective but adherence is low. Clinicians find it difficult to estimate how much treatment people with CF (PWCF) take, whilst objective adherence measurement demonstrates that patients are poorly calibrated with a tendency to over-estimat...

Full description

Bibliographic Details
Main Authors: Louisa Robinson, Chin Maguire, Zhe Hui Hoo, Martin J. Wildman
Format: Article
Language:English
Published: F1000 Research Ltd 2020-01-01
Series:F1000Research
Online Access:https://f1000research.com/articles/8-1904/v2
id doaj-862b5a1db54346b8b03bf896029f2e5f
record_format Article
spelling doaj-862b5a1db54346b8b03bf896029f2e5f2020-11-25T03:08:09ZengF1000 Research LtdF1000Research2046-14022020-01-01810.12688/f1000research.21033.224331Making the invisible visible: the availability and desirability of adherence data in routine CF care– findings from a national questionnaire survey [version 2; peer review: 2 approved]Louisa Robinson0Chin Maguire1Zhe Hui Hoo2Martin J. Wildman3Clinical Trials Research Unit, University of Sheffield, Sheffield, South Yorkshire, S1 4DA, UKClinical Trials Research Unit, University of Sheffield, Sheffield, South Yorkshire, S1 4DA, UKSchool of Health and Related Research, University of Sheffield, Sheffield, Yorkshire, S1 4DA, UKSchool of Health and Related Research, University of Sheffield, Sheffield, Yorkshire, S1 4DA, UKBackground: Inhaled medications for cystic fibrosis (CF) are effective but adherence is low. Clinicians find it difficult to estimate how much treatment people with CF (PWCF) take, whilst objective adherence measurement demonstrates that patients are poorly calibrated with a tendency to over-estimate actual adherence. The diagnostic approach to a PWCF with deteriorating clinical status and very low adherence is likely to be different to the approach to a deteriorating patient with optimal adherence. Access to objective adherence data in routine consultations could help to overcome diagnostic challenges for clinicians and people with CF. Attitudes of clinicians to the use and importance of routinely available adherence data is unknown. Methods: We conducted an online questionnaire survey with UK CF centres. We asked five questions relating to the current use and perception of objective measurements of adherence in routine care. Results: A total of eight CF centres completed the questionnaire. Few of the responding centres have adherence data readily available in routine clinics (13% of centres use medicines possession ratio; of centres with access to I-nebs® it was estimated that 17% of patients had I-neb data regularly available in clinics). All centres considered the availability of objectively measured adherence data to be important. Respondents identified that systems developed to provide adherence data in clinical practice must provide data to both clinicians and patients that is readily understood and easy to use. Conclusions: Centres perceived the availability of adherence data in routine care to be important but objective measures of adherence is rarely available at present.https://f1000research.com/articles/8-1904/v2
collection DOAJ
language English
format Article
sources DOAJ
author Louisa Robinson
Chin Maguire
Zhe Hui Hoo
Martin J. Wildman
spellingShingle Louisa Robinson
Chin Maguire
Zhe Hui Hoo
Martin J. Wildman
Making the invisible visible: the availability and desirability of adherence data in routine CF care– findings from a national questionnaire survey [version 2; peer review: 2 approved]
F1000Research
author_facet Louisa Robinson
Chin Maguire
Zhe Hui Hoo
Martin J. Wildman
author_sort Louisa Robinson
title Making the invisible visible: the availability and desirability of adherence data in routine CF care– findings from a national questionnaire survey [version 2; peer review: 2 approved]
title_short Making the invisible visible: the availability and desirability of adherence data in routine CF care– findings from a national questionnaire survey [version 2; peer review: 2 approved]
title_full Making the invisible visible: the availability and desirability of adherence data in routine CF care– findings from a national questionnaire survey [version 2; peer review: 2 approved]
title_fullStr Making the invisible visible: the availability and desirability of adherence data in routine CF care– findings from a national questionnaire survey [version 2; peer review: 2 approved]
title_full_unstemmed Making the invisible visible: the availability and desirability of adherence data in routine CF care– findings from a national questionnaire survey [version 2; peer review: 2 approved]
title_sort making the invisible visible: the availability and desirability of adherence data in routine cf care– findings from a national questionnaire survey [version 2; peer review: 2 approved]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2020-01-01
description Background: Inhaled medications for cystic fibrosis (CF) are effective but adherence is low. Clinicians find it difficult to estimate how much treatment people with CF (PWCF) take, whilst objective adherence measurement demonstrates that patients are poorly calibrated with a tendency to over-estimate actual adherence. The diagnostic approach to a PWCF with deteriorating clinical status and very low adherence is likely to be different to the approach to a deteriorating patient with optimal adherence. Access to objective adherence data in routine consultations could help to overcome diagnostic challenges for clinicians and people with CF. Attitudes of clinicians to the use and importance of routinely available adherence data is unknown. Methods: We conducted an online questionnaire survey with UK CF centres. We asked five questions relating to the current use and perception of objective measurements of adherence in routine care. Results: A total of eight CF centres completed the questionnaire. Few of the responding centres have adherence data readily available in routine clinics (13% of centres use medicines possession ratio; of centres with access to I-nebs® it was estimated that 17% of patients had I-neb data regularly available in clinics). All centres considered the availability of objectively measured adherence data to be important. Respondents identified that systems developed to provide adherence data in clinical practice must provide data to both clinicians and patients that is readily understood and easy to use. Conclusions: Centres perceived the availability of adherence data in routine care to be important but objective measures of adherence is rarely available at present.
url https://f1000research.com/articles/8-1904/v2
work_keys_str_mv AT louisarobinson makingtheinvisiblevisibletheavailabilityanddesirabilityofadherencedatainroutinecfcarefindingsfromanationalquestionnairesurveyversion2peerreview2approved
AT chinmaguire makingtheinvisiblevisibletheavailabilityanddesirabilityofadherencedatainroutinecfcarefindingsfromanationalquestionnairesurveyversion2peerreview2approved
AT zhehuihoo makingtheinvisiblevisibletheavailabilityanddesirabilityofadherencedatainroutinecfcarefindingsfromanationalquestionnairesurveyversion2peerreview2approved
AT martinjwildman makingtheinvisiblevisibletheavailabilityanddesirabilityofadherencedatainroutinecfcarefindingsfromanationalquestionnairesurveyversion2peerreview2approved
_version_ 1724667210183475200